Video Experimental Relacionado

Updated: May 5, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Un estudio sistemático sobre la exposición prenatal a los opiáceos: una revisión de las consecuencias del desarrollo

Quyen Cao¹, Julie Kable²

¹Neuroscience and Behavioral Biology Department, Emory University, Atlanta, GA; and.

Journal of developmental and behavioral pediatrics : JDBP

|August 27, 2025

Resumen

La exposición prenatal a los opiáceos plantea riesgos para el desarrollo neurológico, especialmente en los ámbitos neurosensorial y socioemocional. El uso de opiáceos por parte de la madre requiere monitorear el desarrollo neurológico del niño.

Área de la Ciencia:

La neurociencia
Psicología del desarrollo
Salud pública

Sus antecedentes:

La exposición prenatal a los opiáceos es una preocupación creciente con posibles efectos a largo plazo en el desarrollo infantil.
La comprensión de los impactos específicos en el desarrollo neurológico es crucial para la intervención y el apoyo tempranos.

Objetivo del estudio:

Revisar y evaluar sistemáticamente los impactos adversos en el desarrollo neurológico relacionados con la exposición prenatal a opioides.
Para sintetizar los hallazgos en varios dominios neuroconductuales y de neuroimagen.

Principales métodos:

La revisión sistemática se realizará de acuerdo con las directrices de las partidas de información preferidas para las revisiones sistemáticas y los metanálisis (PRISMA).
Se incluyen 86 estudios, evaluados mediante el sistema de clasificación de recomendaciones, evaluación, desarrollo y evaluaciones (GRADE).
Los resultados se clasifican en 6 dominios neuroconductuales y 1 dominio de neuroimagen.

Principales resultados:

El dominio neurosensorial mostró el mayor riesgo de deterioro (76,9%) en niños con exposición prenatal a opiáceos.
El dominio socioemocional exhibió el mayor tamaño de efecto para el impacto negativo (g de Hedge = -1.14).
Los estudios de neuroimagen fueron limitados y heterogéneos, lo que obstaculizó las conclusiones definitivas.

Conclusiones:

El uso de opiáceos por parte de la madre durante el embarazo es un indicador de riesgo para el seguimiento del desarrollo.
Los efectos teratogénicos directos son difíciles de determinar debido a factores de confusión como el uso simultáneo de sustancias y la adversidad social.

Palabras clave:

desarrollo neurológico Neuroimágenes Los opiáceos el embarazo análisis sistémico

Más Videos Relacionados

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

Videos de Conceptos Relacionados

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Drug Abuse and Addiction: Pharmacological Phenomena

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...

Opioid Receptors: Overview

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...